Fed Contender Kevin Warsh Signals Rates Stay Higher for Longer, Pharma Dividend Stocks in Focus
Warsh's comments point to a tougher rate environment, but analysts say pharmaceutical dividend payers may hold up better than feared.
Kevin Warsh signaled the Federal Reserve is likely to keep interest rates higher for longer, a stance that could pressure pharmaceutical stocks but by less than some investors expect.